Targeting KRAS-Mutant Non–Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting KRAS-Mutant Non–Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations

Published:2020-12-10 Issue:35 Volume:38 Page:4208-4218
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Burns Timothy F.¹,Borghaei Hossein²^ORCID,Ramalingam Suresh S.³^ORCID,Mok Tony S.⁴,Peters Solange⁵^ORCID

Affiliation:

1. University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA

2. Fox Chase Cancer Center, Philadelphia, PA

3. Division of Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA

4. State Laboratory of Translational Oncology, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong

5. Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, Switzerland

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.00744

Reference108 articles.

1. KRAS-Mutant non-small cell lung cancer: From biology to therapy

2. Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

3. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

4. Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

5. KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics of patients with KRAS mutation detected by liquid biopsy;Thoracic Cancer;2023-09-26

2. Targeted Therapies for Previously “Undruggable” KRAS-Mutated Non–Small Cell Lung Cancer: A Review of Sotorasib and Adagrasib;Annals of Pharmacotherapy;2023-09-12

3. Breaking the ‘Undruggable’ Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations—A Comprehensive Review and Description of Single Site Experience;Cancers;2023-07-23

4. Tumor matrix stiffness provides fertile soil for cancer stem cells;Cancer Cell International;2023-07-20

5. Molecular profiling of solid tumors by next-generation sequencing: an experience from a clinical laboratory;Frontiers in Oncology;2023-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3